Le Lézard
Classified in: Health
Subjects: LAW, POL

As the correctional ombudsman, the Ombudsperson is critical of correctional facility flaws


2016-2017 Annual Report? Release no. 4

QUÉBEC CITY, Sept. 28, 2017 /CNW Telbec/ - In her 2016-2017 Annual Report, tabled today in the National Assembly, the Ombudsperson describes the flaws found in correctional facilities: "The investigations we conducted showed that in certain cases, there were restrictions on visiting hours, medical staff shortages, closure of certain services and cancellation of rehabilitation programs. This runs counter to the goal of rehabilitating detainees," said Ombudsperson Marie Rinfret, who also acts as Québec's correctional ombudsman. (p. 78)

Marie Rinfret, Ombudsperson (CNW Group/Protecteur du citoyen)

Other findings:

 

SOURCE Protecteur du citoyen


These press releases may also interest you

at 22:16
On May 10, 2024, the impactful international academic journal, Science Immunology, a sub-journal of Science, published a research paper titled "Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system...

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...



News published on and distributed by: